FORMULATION DEVELOPMENT OF COLON TARGETED MESALAMINE PELLETS: IN VITRO-IN VIVO RELEASE STUDY

Authors

  • JAGAN BAHEKAR School of Pharmacy, Swami Ramanand Teerth Marathwada University, Nanded 431606, Maharashtra, India
  • SHAILESH WADHER School of Pharmacy, Swami Ramanand Teerth Marathwada University, Nanded 431606, Maharashtra, India

DOI:

https://doi.org/10.22159/ijap.2019v11i6.34920

Keywords:

pH sensitive, Time dependent, Wurster coating, Colon targeting, Mesalamine, Pellets

Abstract

Objective: This study was intended to investigate the potential of the colon specificity approach comprising of use of pH-sensitive and time-dependent polymers in combination for precise colonic release of Mesalamine or 5-Aminosalicylic acid (5-ASA).

Methods: The extrusion and spheronization method, preferably employed in industry for allowing high dose capacity to formulate, was used to prepare drug pellets. The Wurster coating technique used for aqueous coatings of Eudragit NE 40D as an inner coat and Eudragit FS30D as outer coat. The changing pH media used for in vitro release study of optimization batches for both the coating levels. A scanning electron microscope (SEM) was used to evaluate coating thickness and surface morphology.

Results: The pharmacokinetic parameters of formulation evaluated by in vivo study in rabbits revealed that the uncoated formulation released the drug too early in the gastrointestinal tract (GIT) with a mean Cmax of 1205.28±0.37 µg/ml at 2 h after administration, whereas desired lag time was achieved in case of coated pellets exhibiting mean Cmax 465.94±0.21 µg/ml and tmax of 8 h.

Conclusion: The in vitro and in vivo release study divulge the reliability of approach involving the use of pH sensitivity and time dependency of polymer for drug release in a single formulation for the treatment of colonic diseases. Hence, the present study provides constructive results for colon targeting of 5-ASA pellets with industrially feasible processes.

Downloads

Download data is not yet available.

References

Jain A, Gupta Y, Jain SK. Perspectives of biodegradable natural polysaccharides for site-specific drug delivery to the colon. J Pharm Pharm Sci 2007;10:86-128.

Michael W, Diana H, Marcus T, Achim W, Thomas H. Degradation studies of modified inulin as a potential encapsulation material for colon targeting and release of mesalamine. Carbohydr Polym 2018;199:102-8.

Karthika C, Sureshkumar R, Suhail A. Formulation development and in vitro evaluation of curcumin-loaded solid self-nano emulsifying drug delivery system for colon carcinoma. Asian J Pharm Clin Res 2019;12:243-7.

Nagasamy VD, Shashikumar S, Rajeshkumar R. Sustained release microbeads of Ritonavir: in vitro and in vivo evaluation. Int J Appl Pharm 2019;11:189-98.

Haddish Berhane N, Farhadi A, Nyquist C, Haghighi K, Keshavarzian A. Biological variability and targeted delivery of therapeutics for inflammatory bowel diseases: an in silico approach. Inflammation Allergy: Drug Targets 2007;6:47-55.

Mahida Y, Lamming C, Gallagher A, Hawthorne A, Hawkey C. 5-aminosalicylic acid is a potent inhibitor of interleukin 1 beta production in organ culture of colonic biopsy specimens from patients with inflammatory bowel disease. Gut 1991;32:50-4.

Cominelli F, Nast C, Duchini A, Lee M. Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis. Gastroenterol 1992;103:65-71.

Yang L, Chu J, Fix J. Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. Int J Pharm 2002;235:1-15.

Das MK, Ahmed A, Saha D. Microsphere a drug delivery system-a review. Int J Curr Pharm Res 2019;11:34-41.

Ubgade S, Kilor V, Bahekar V, Ittadwar A. Formulation development of immediate-release pellets of tadalafil: solidification approach for nanosuspension. Int J Appl Pharm 2019;11:124-31.

Laila FA, Chandran S. Multiparticulate formulation approach to colon-specific drug delivery: current perspectives. J Pharm Pharm Sci 2006;9:327-38.

Kramar A, Turk S, Vrecer F. Statistical optimization of diclofenac sustained-release pellets coated with polymethacrylic films. Int J Pharm 2003;256:43-52.

Gupta SK, Huneza A, Patra S. Formulation, development and in vitro evaluation of Tramadol extended-release tablets. Int J Pharm Pharm Sci 2019;11:63-73.

Mane SR. Advances of Hydrazone linker in polymeric drug delivery. J Crit Rev 2019;6:1-4.

Gada S, Anandkumar Y, Setty CM. Drumstick mucilage microspheres for controlled release of lamivudine: design, optimization and in vitro evaluation. Int J Pharm Pharm Sci 2019;11:60-8.

Pinto JF. Site-specific drug delivery systems within the gastro-intestinal tract: from the mouth to the colon. Int J Pharm 2010;395:44-52.

Sinha VR, Kumria R. Microbially triggered drug delivery to the colon. Eur J Pharm Sci 2003;18:3-18.

Gazzaniga A, Iamartino P, Maffione G, Sangalli ME. Oral delayed-release system for colonic specific delivery. Int J Pharm 1994;108:77-83.

Zhang L, Chen DW, Gao ZB. Drug release mechanism of famotidine time-controlled release pellets. Acta Pharm Sin 2006;41:873-7.

Davis SS, Hardy JG, Taylor MJ, Stockwell A, Whalley DR, Wilson CG. The in vivo evaluation of an osmotic device (osmet) using gamma scintigraphy. J Pharm Pharmacol 1984;36:740-2.

Thomas P, Richards D, Richards A, Rojers L, Evans BK, Drew MJ, et al. Absorption of delayed-release prednisolone in ulcerative colitis and Crohn's disease. J Pharm Pharmacol 1985;37:757-8.

Sasaki Y, Hada R, Nakajima H, Fukuda S, Munakata A. Improved localizing method of radiopill in the measurement of entire gastrointestinal pH profiles: colonic luminal pH in normal subjects and patients with Crohn’s disease. Am J Gastroenterol 1997;92:114-8.

Evans DF, Pye G, Bramley R, Clark AG, Dyson TJ, Hardcastle JD. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 1988;29:1035-41.

Lamprecht A, Kawashima Y. pH-sensitive microparticles for oral drug delivery. J Drug Delivery Sci Technol 2006;16:26-34.

Akhgari A, Garekani HA, Sadeghi F, Azimaie M. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery. Int J Pharm 2005;305:22-30.

Rubinstein A. Microbially controlled drug delivery to the colon. Biopharm Drug Dispos 1990;11:465-75.

Kadam VD, Gattani SG. Development of colon targeted multiparticulate pulsatile drug delivery for treating nocturnal asthma. Drug Delivery 2010;17:343-51.

Gao C, Huang J, Jiao Y, Shan L, Liu Y, Li Y, et al. In vitro release and in vivo absorption in beagle dogs of meloxicam from Eudragit ® FS 30 D-coated pellets. Int J Pharm 2006;322:104-12.

Gangurde H, Chordiya M, Tamizharasi S, Sivakumar T. Statistical optimization of mesalamine coated pellets for possible ileocecal targeting. Mahidol Uni J Pharma Sci 2013;40:25-44.

Cristina F, Fridrun P, Dinora F, Francisco V, Joao S, Angelina P. Assessment of the in vivo drug release from pellets film-coated with a dispersion of high amylose starch and ethylcellulose for potential colon delivery. J Pharm Pharmacol 2010;62:55-61.

Ghebre Sellassie I, Martin C. Pharmaceutical extrusion technology. Marcel Dekker, Inc., New York; 2003.

Sriamornsak P, Nunthanid J, Luangtana-anan M, Puttipipatkhachorn S. Alginate-based pellets prepared by extrusion/spheronization: a preliminary study on the effect of additive in granulating liquid. Eur J Pharm Biopharm 2007;67:227-35.

Vervaet C, Baert L, Remon JP. Extrusion-spheronisation a literature review. Int J Pharm 1995;116:131-46.

Hileman GA, Goskonda SR, Spalitto AJ, Upadrashta SM. Response surface optimization of high dose pellets by extrusion and spheronization. Int J Pharm 1993;100:71-9.

Knop K. Influence of buffer solution composition on drug release from pellets coated with neutral and quaternary acrylic polymers and on swelling of free polymer films. Eur J Pharm Sci 1996;4:293-300.

Zhao X, Li G, Zhang L, Tao X, Guan T, Hong M, et al. Preparation and evaluation of nicotinic acid sustained-release pellets combined with immediate release simvastatin. Int J Pharm 2010;400:42-8.

Amighi K, Moes AJ. Influence of curing conditions on the drug release rate from Eudragit® NE40D filmcoated sustained-release theophylline pellets. STP Pharma Sci 1997;7:141-7.

Kotla NG, Gulati M, Singh SK, Shivapooja A. Facts, fallacies and future of dissolution testing of polysaccharide-based colon-specific drug delivery. J Controlled Release 2014;178:55–62.

Dukic Ott A, Beer TD, Remon JP, Baeyens W, Foreman P, Vervaet C. In vitro and in vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronization. Eur J Pharm Biopharm 2008;70:302-12.

Gidenne T. Effect of fibre level, particle size and adaptation period on digestibility and rate of passage as measured at the ileum and in the faeces in the adult rabbit. Br J Nutr 1992;67:133–46.

Harcourt Brown F, Harcourt Brown N. Textbook of rabbit medicine. Oxford (UK): Butterworth Heinemann; 2002.

Zhou SY, Fleisher D, Pao LH, Li C, Winward B, Zimmermann EM, et al. Intestinal metabolism and transport of 5-aminosalicylate. Drug Metab Dispos 1999;27:479–85.

Published

07-11-2019

How to Cite

BAHEKAR, J., & WADHER, S. . (2019). FORMULATION DEVELOPMENT OF COLON TARGETED MESALAMINE PELLETS: IN VITRO-IN VIVO RELEASE STUDY. International Journal of Applied Pharmaceutics, 11(6), 125–132. https://doi.org/10.22159/ijap.2019v11i6.34920

Issue

Section

Original Article(s)